Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by eczematous lesions and severe itching. However, its pathogenesis has not yet been fully elucidated. The aim of this study was to investigate the causal relationship between plasma proteins and AD, as well as to identify and quantify the potential roles of immune cell phenotypes as mediators. Methods: We utilized summary-level data from genome-wide association studies and conducted a two-sample Mendelian randomization (MR) analysis involving 4,907 circulating plasma proteins, 731 immune cell phenotypes, and AD. Initially, we conducted bidirectional univariate MR analyses to forecast causal effects linking circulating plasma proteins and AD. Subsequently, we employed a two-step MR analysis to scrutinize the immune cell phenotypes that could mediate these effects. The inverse variance weighted was the main method employed for MR analysis, while the Cochran’s Q test and MR-Egger intercept test were used to assess the presence of heterogeneity and pleiotropy, respectively. We then determined whether our results could be influenced by individual single-nucleotide polymorphisms using the “leave-one-out” test. Results: Positive correlations were observed between KRT1, IL18R1, and SEMA6A and the risk of AD, whereas BDH2, ADAMTS3, ANKRD1, TIAM1, MID2, and IFNA16 all showed negative correlations with the risk of AD. Mediation analysis indicated that CD8 on CM CD8br cells acted as a mediator between IFNA16 and AD, with a mediation effect proportion of 11.2%. In addition, sensitivity analyses did not reveal significant heterogeneity or level pleiotropy. Conclusion: Our findings indicated the presence of a one-way causal relationship between the circulating plasma protein IFNA16 and AD. This study also explored immune cell phenotypes that may serve as mediators, offering novel insights into the etiology, pathogenesis, and potential clinical interventions in AD. Nevertheless, these findings need to be validated by clinical and laboratory studies.

1.
Zhu
Y
,
Liu
Y
,
Ma
Y
,
Chen
L
,
Huang
H
,
Huang
S
, et al
.
Macrophage autophagy deficiency-induced CEBPB accumulation alleviates atopic dermatitis via impairing M2 polarization
.
Cell Rep
.
2023
;
42
(
11
):
113430
.
2.
Yang
J
,
He
X
,
Qian
L
,
Zhao
B
,
Fan
Y
,
Gao
F
, et al
.
Association between plasma proteome and childhood neurodevelopmental disorders: a two-sample Mendelian randomization analysis
.
EBioMedicine
.
2022
;
78
:
103948
.
3.
Leung
D
,
Bissonnette
R
,
Kreimer
S
,
Berdyshev
E
,
Bafna
S
,
Lyubchenko
T
, et al
.
Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin
.
J Allergy Clin Immunol Pract
.
2023
;
11
(
5
):
1421
8
.
4.
Emdin
CA
,
Khera
AV
,
Kathiresan
S
.
Mendelian randomization
.
JAMA
.
2017
;
318
(
19
):
1925
6
.
5.
Gao
B
,
Wang
Z
,
Wang
K
,
Lei
Y
,
Zhuang
Y
,
Zhou
Z
, et al
.
Relationships among gut microbiota, plasma metabolites, and juvenile idiopathic arthritis: a mediation Mendelian randomization study
.
Front Microbiol
.
2024
;
15
:
1363776
.
6.
Skrivankova
VW
,
Richmond
RC
,
Woolf
B
,
Yarmolinsky
J
,
Davies
NM
,
Swanson
SA
, et al
.
Strengthening the reporting of observational studies in Epidemiology using mendelian randomization: the STROBE-MR statement
.
JAMA
.
2021
;
326
(
16
):
1614
21
.
7.
Ferkingstad
E
,
Sulem
P
,
Atlason
BA
,
Sveinbjornsson
G
,
Magnusson
MI
,
Styrmisdottir
EL
, et al
.
Large-scale integration of the plasma proteome with genetics and disease
.
Nat Genet
.
2021
;
53
(
12
):
1712
21
.
8.
Orrù
V
,
Steri
M
,
Sidore
C
,
Marongiu
M
,
Serra
V
,
Olla
S
, et al
.
Complex genetic signatures in immune cells underlie autoimmunity and inform therapy
.
Nat Genet
.
2020
;
52
(
10
):
1036
45
.
9.
Yang
K
,
Li
S
,
Ding
Y
,
Meng
X
,
Zhang
C
,
Sun
X
.
Effect of smoking-related features and 731 immune cell phenotypes on esophageal cancer: a two-sample and mediated Mendelian randomized study
.
Front Immunol
.
2024
;
15
:
1336817
.
10.
Li
J
,
Wei
J
,
Wang
J
,
Xu
T
,
Wu
B
,
Yang
S
, et al
.
Association between gut microbiota and spinal stenosis: a two-sample mendelian randomization study
.
Front Immunol
.
2024
;
15
:
1360132
.
11.
Mekchay
S
,
Pothakam
N
,
Norseeda
W
,
Supakankul
P
,
Teltathum
T
,
Liu
G
, et al
.
Association of IFNA16 and TNFRSF19 polymorphisms with intramuscular fat content and fatty acid composition in pigs
.
Biology
.
2022
;
11
(
1
):
109
.
12.
Kopfnagel
V
,
Wagenknecht
S
,
Harder
J
,
Hofmann
K
,
Kleine
M
,
Buch
A
, et al
.
RNase 7 strongly promotes TLR9-mediated DNA sensing by human plasmacytoid dendritic cells
.
J Invest Dermatol
.
2018
;
138
(
4
):
872
81
.
13.
Gill
MA
,
Bajwa
G
,
George
TA
,
Dong
CC
,
Dougherty
II
,
Jiang
N
, et al
.
Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells
.
J Immunol
.
2010
;
184
(
11
):
5999
6006
.
14.
Durrani
SR
,
Montville
DJ
,
Pratt
AS
,
Sahu
S
,
DeVries
MK
,
Rajamanickam
V
, et al
.
Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children
.
J Allergy Clin Immunol
.
2012
;
130
(
2
):
489
95
.
15.
Huber
JP
,
Ramos
HJ
,
Gill
MA
,
Farrar
JD
.
Cutting edge: type I IFN reverses human Th2 commitment and stability by suppressing GATA3
.
J Immunol
.
2010
;
185
(
2
):
813
7
.
16.
Chen
YH
,
Bieneman
AP
,
Creticos
PS
,
Chichester
KL
,
Schroeder
JT
.
IFN-alpha inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release
.
J Allergy Clin Immunol
.
2003
;
112
(
5
):
944
50
.
17.
Mueller
RS
,
Hartmann
K
.
Interferon therapies in small animals
.
Vet J
.
2021
;
271
:
105648
.
18.
Korsten
P
,
Tampe
B
.
A transcriptome array-based approach links proteinuria and distinct molecular signatures to intrarenal expression of type I interferon IFNA5 in lupus nephritis
.
Int J Mol Sci
.
2023
;
24
(
13
):
10636
.
19.
Zitvogel
L
,
Galluzzi
L
,
Kepp
O
,
Smyth
MJ
,
Kroemer
G
.
Type I interferons in anticancer immunity
.
Nat Rev Immunol
.
2015
;
15
(
7
):
405
14
.
20.
Cole
DK
,
Gao
GF
.
CD8: adhesion molecule, co-receptor and immuno-modulator
.
Cell Mol Immunol
.
2004
;
1
(
2
):
81
8
.
21.
Zhang
Z
,
Zheng
W
,
Xie
H
,
Chai
R
,
Wang
J
,
Zhang
H
, et al
.
Up-regulated expression of substance P in CD8(+) T cells and NK1R on monocytes of atopic dermatitis
.
J Transl Med
.
2017
;
15
(
1
):
93
.
22.
Hennino
A
,
Jean-Decoster
C
,
Giordano-Labadie
F
,
Debeer
S
,
Vanbervliet
B
,
Rozières
A
, et al
.
CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis
.
J Allergy Clin Immunol
.
2011
;
127
(
4
):
1064
7
.
23.
Hsu
YA
,
Huang
CC
,
Kung
YJ
,
Lin
HJ
,
Chang
CY
,
Lee
KR
, et al
.
The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6
.
Cancer Lett
.
2016
;
375
(
2
):
303
12
.
24.
Lewis
JA
,
Huq
A
,
Najarro
P
.
Inhibition of mitochondrial function by interferon
.
J Biol Chem
.
1996
;
271
(
22
):
13184
90
.
25.
Buang
N
,
Tapeng
L
,
Gray
V
,
Sardini
A
,
Whilding
C
,
Lightstone
L
, et al
.
Type I interferons affect the metabolic fitness of CD8(+) T cells from patients with systemic lupus erythematosus
.
Nat Commun
.
2021
;
12
(
1
):
1980
.
26.
Mohty
AM
,
Grob
JJ
,
Mohty
M
,
Richard
MA
,
Olive
D
,
Gaugler
B
.
Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma
.
Immunobiology
.
2010
;
215
(
2
):
113
23
.
27.
Gu
J
,
Qiao
Y
,
Cong
S
.
Causal role of immune cells on risk of Parkinsonʼs disease: a Mendelian randomization study
.
Front Aging Neurosci
.
2024
;
16
:
1368374
.
You do not currently have access to this content.